University of Zurich
Overview
The University of Zurich is a public research university in Switzerland that supports the commercialization of research and the creation of spin-off companies through grants, fellowships, and its dedicated technology transfer office, Unitectra.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Anaveon | Feb 2019 | Series A | Co-investor |
| Cellerys AG | Oct 2015 | Accelerator | Co-investor |
| Synthara AG | Sep 2020 | Seed | Co-investor |
| CUTISS AG | Aug 2017 | Convertible Debt | Lead |
| EraCal Therapeutics | Oct 2019 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is University of Zurich based?
University of Zurich is headquartered in Zurich, Switzerland.
When was University of Zurich founded?
University of Zurich was founded in 1833.
How many portfolio companies does University of Zurich have?
University of Zurich has 11 portfolio companies in Caplight's dataset.
What are some companies in University of Zurich's portfolio?
Portfolio companies visible on Caplight include Anaveon, Cellerys AG, Synthara AG, CUTISS AG, EraCal Therapeutics.
What was University of Zurich's most recent investment shown here?
University of Zurich's most recent investment in this portfolio sample was in Synthara AG in 2020.
What sectors does University of Zurich focus on?
University of Zurich focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does University of Zurich focus on?
Stage focus information for University of Zurich is not publicly available.